Compare AbCellera Biologics Inc (ABCL) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Lucid Group Inc — how do they compare? AbCellera Biologics Inc trades at $8.93 (market cap $2.99B), while Lucid Group Inc trades at $6.7 (market cap $2.64B). The key difference: AbCellera Biologics Inc and Lucid Group Inc are close in size by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | LCID | |
|---|---|---|
Market Cap | $2.99B | $2.64B |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $24.77 |
52-Week Low | $2.78 | $4.62 |
Enterprise Value | $2.58B | $5.54B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
